The clinical management of BRCA1 and BRCA2 mutation carriers
@article{Gulati2006TheCM, title={The clinical management of BRCA1 and BRCA2 mutation carriers}, author={A. P. Gulati and S. Domchek}, journal={Current Oncology Reports}, year={2006}, volume={10}, pages={47-53} }
Mutations in the cancer susceptibility genes BRCA1 and BRCA2 are associated with significantly increased risks of breast and ovarian cancer. Fortunately, effective strategies are available to reduce these risks, including genetic testing, which is an important consideration in determining management of patients with a strong family history of cancer. This article reviews the current evidence for risk-reducing strategies in BRCA1 and BRCA2 mutation carriers and outlines future research… CONTINUE READING
Topics from this paper
9 Citations
Guidelines for complex genetic analysis of hereditary breast ovarian cancer syndrome in slovak population
- Medicine
- 2015
- PDF
Mammographic parenchymal patterns as an imaging marker of endogenous hormonal exposure: a preliminary study in a high-risk population.
- Medicine
- Academic radiology
- 2013
- 8
Mammographic parenchymal texture as an imaging marker of hormonal activity: a comparative study between pre- and post-menopausal women
- Medicine, Engineering
- Medical Imaging
- 2011
- 2
- PDF
The influence of genetic factors on brain plasticity and recovery after neural injury.
- Medicine
- Current opinion in neurology
- 2012
- 27
DCPIP (2,6-dichlorophenolindophenol) as a genotype-directed redox chemotherapeutic targeting NQO1*2 breast carcinoma
- Biology, Medicine
- Free radical research
- 2011
- 12
Clinical classification of BRCA1 DNA missense variants: H1686Q is a novel pathogenic mutation occurring in the ontogenetically invariant THV motif of the N-terminal BRCT domain.
- Medicine
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- 2008
- 14
References
SHOWING 1-10 OF 56 REFERENCES
Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2
- Biology, Medicine
- Science
- 2003
- 1,490
Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies
- Medicine
- Journal of Medical Genetics
- 2005
- 141
- PDF
Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.
- Medicine
- JAMA
- 2006
- 648
- PDF
Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
- Medicine
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- 2004
- 666
- PDF
Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers.
- Medicine
- Journal of the National Cancer Institute
- 2001
- 687
Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study.
- Medicine
- The Lancet. Oncology
- 2007
- 220
The role of BRCA1 in the cellular response to chemotherapy.
- Biology, Medicine
- Journal of the National Cancer Institute
- 2004
- 384
- PDF
Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.
- Medicine
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- 2005
- 438
Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study.
- Medicine
- Journal of the National Cancer Institute
- 2003
- 93
- PDF